Literature DB >> 14897704

Use of triethylene melamine in treatment of leukemia and leukosarcoma.

J H SILVERBERG, W DAMESHEK.   

Abstract

Entities:  

Keywords:  LEUKEMIA/therapy; LEUKOSARCOMA/therapy; TRIETHYLENE MELAMINE/therapeutic use

Mesh:

Substances:

Year:  1952        PMID: 14897704     DOI: 10.1001/jama.1952.02930120037009

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN: 0002-9955


× No keyword cloud information.
  7 in total

1.  TRYPSIN in thrombo-embolic disease.

Authors: 
Journal:  Br Med J       Date:  1955-06-04

2.  The chemical control of cancer.

Authors:  J F HOLLAND
Journal:  Public Health Rep       Date:  1954-12       Impact factor: 2.792

3.  Lymphoblastomas in childhood; cutaneous manifestations.

Authors:  L M NELSON
Journal:  Calif Med       Date:  1953-03

4.  Chemical agents in neoplastic diseases; an evaluation of chemotherapeutic substances for clinical management.

Authors:  H R BIERMAN
Journal:  Calif Med       Date:  1953-01

5.  BACTERIA at the sea bottom.

Authors: 
Journal:  Br Med J       Date:  1952-06-21

6.  6,N 2-Diaryl-1,3,5-triazine-2,4-diamines: synthesis, antiproliferative activity and 3D-QSAR modeling.

Authors:  Ahmad Junaid; Felicia Phei Lin Lim; Lay Hong Chuah; Anton V Dolzhenko
Journal:  RSC Adv       Date:  2020-03-25       Impact factor: 4.036

7.  New therapy for leukemia, polycythemia, and lymphoma.

Authors:  A A MARLOW; G R BARTLETT
Journal:  Calif Med       Date:  1953-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.